Asymptomatic Left Bundle Branch Block Predicts New-Onset Congestive Heart Failure and Death From Cardiovascular

Peyman N Azadani1, Ata Soleimanirahbar2, Gregory M Marcus2

  • 1Penn State Hershey Medical Center, PA, USA.

Cardiology Research
|March 30, 2017
PubMed

Insights

Left bundle branch block (LBBB) is linked to increased risk of new congestive heart failure (CHF) and cardiovascular death, even without prior heart disease. Early detection and intervention for LBBB may improve outcomes.

Area of Science:

  • Cardiology
  • Electrocardiography
  • Public Health

Background:

  • Left bundle branch block (LBBB) is a potential risk factor for cardiovascular morbidity and mortality.
  • The association requires further characterization in individuals without pre-existing heart conditions.

Purpose of the Study:

  • To assess the association between LBBB and new-onset congestive heart failure (CHF) or cardiovascular death.
  • To investigate LBBB as a predictor in a population free of clinical heart disease.

Main Methods:

  • The study analyzed 1,688 participants (>55 years) from the community-based SPPARCS cohort.
  • ECGs and medical history were collected every 2 years for 6 years.
  • LBBB at baseline or year 2 predicted CHF and cardiovascular death at years 4 and 6.

Main Results:

  • The prevalence of LBBB at baseline was 2.5% (42 participants).
  • LBBB was associated with a significantly higher incidence of new CHF (OR: 2.85, P=0.047) and cardiovascular death (OR: 2.35, P=0.044) after adjusting for confounders.
  • These associations persisted even in the absence of clinically detectable heart disease.

Conclusions:

  • Asymptomatic LBBB is associated with increased risk of new-onset CHF and cardiovascular mortality.
  • Further research is needed to explore diagnostic testing and early treatment strategies for asymptomatic LBBB to reduce cardiovascular events.
Abstract

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
778
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
1.0K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.3K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
496
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
714